Evidence map›Paper›PMID 24477453›Full record

Trial reportIntensive care medicine2014

Cerebral metabolic effects of exogenous lactate supplementation on the injured human brain.

Pierre Bouzat, Nathalie Sala, Tamarah Suys, Jean-Baptiste Zerlauth, Pedro Marques-Vidal, François Feihl, Jocelyne Bloch, Mahmoud Messerer, Marc Levivier, Reto Meuli and 2 more

Registry-linked trialOpen access · greenAbstract readClinical Trial, Phase II
PubMed Publisher
In one paragraph

Trial report in Intensive care medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02776488 (Exogenous Sodium Lactate Infusion in Traumatic Brain Injury), which is not on this map. Cited by 114 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 3 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02776488 phase2withdrawnnot on this mapstarted 2020, after this paper: background citation

Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)

TypeinterventionalSponsorUniversity of California, Los AngelesRan2020 to 2026Enrolled0ConditionsBrain Injuries, TraumaticArmsSodium Lactate, Placebo
3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 3 syntheses or guidelines pooled it, 185 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Observational
  17. Review
  18. Review
  19. Article
  20. Review

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Pierre BouzatDepartment of Intensive Care Medicine, Neuroscience Critical Care Research Group, Faculty of Biology and Medicine, University Hospital of Lausanne, Rue du Bugnon 46, 1011, Lausanne, Switzerland, PBouzat@chu-grenoble.fr.
Nathalie Sala
Tamarah Suys
Jean-Baptiste Zerlauth
Pedro Marques-Vidal
François Feihl
Jocelyne Bloch
Mahmoud Messerer
Marc Levivier
Reto Meuli
Pierre J Magistretti
Mauro Oddo
University Hospital of Lausanne · CHInstitute of Social and Preventive Medicine · CHUniversité Joseph Fourier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeExperimental evidence suggests that lactate is neuroprotective after acute brain injury; however, data in humans are lacking. We examined whether exogenous lactate supplementation improves cerebral energy metabolism in humans with traumatic brain injury (TBI).

methodsWe prospectively studied 15 consecutive patients with severe TBI monitored with cerebral microdialysis (CMD), brain tissue PO2 (PbtO2), and intracranial pressure (ICP). Intervention consisted of a 3-h intravenous infusion of hypertonic sodium lactate (aiming to increase systemic lactate to ca. 5 mmol/L), administered in the early phase following TBI. We examined the effect of sodium lactate on neurochemistry (CMD lactate, pyruvate, glucose, and glutamate), PbtO2, and ICP.

resultsTreatment was started on average 33 ± 16 h after TBI. A mixed-effects multilevel regression model revealed that sodium lactate therapy was associated with a significant increase in CMD concentrations of lactate [coefficient 0.47 mmol/L, 95% confidence interval (CI) 0.31-0.63 mmol/L], pyruvate [13.1 (8.78-17.4) μmol/L], and glucose [0.1 (0.04-0.16) mmol/L; all p < 0.01]. A concomitant reduction of CMD glutamate [-0.95 (-1.94 to 0.06) mmol/L, p = 0.06] and ICP [-0.86 (-1.47 to -0.24) mmHg, p < 0.01] was also observed.

conclusionsExogenous supplemental lactate can be utilized aerobically as a preferential energy substrate by the injured human brain, with sparing of cerebral glucose. Increased availability of cerebral extracellular pyruvate and glucose, coupled with a reduction of brain glutamate and ICP, suggests that hypertonic lactate therapy has beneficial cerebral metabolic and hemodynamic effects after TBI.

Indexed as

AdultBrainBrain Injuries, TraumaticEnergy MetabolismFemaleFrontal LobeGlucoseHumansInfusions, IntravenousLactic AcidMaleMicrodialysisMiddle AgedNeuroprotectionProspective StudiesPyruvic AcidGlucoseLactic AcidPyruvic AcidSodium Lactate

Identifiers

PMID24477453
OpenAlexW2110429413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.